Search
Smith & Nephew PLC
SNNAdd to Watchlist
30.290USD
+0.250+0.83%
Close 06/29, 16:00（ET）Quotes delayed by 15 min
12.81BMarket Cap
26.95P/E TTM
More Details of Smith & Nephew PLC Company
Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing, and selling medical devices and services. It is focused on the repair, regeneration, and replacement of soft and hard tissue. The Company's segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip, knee and shoulder implants used to replace diseased, damaged or worn joints, robotics-assisted enabling technologies that empower surgeons, and trauma products used to stabilise severe fractures and correct bone deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.
Smith & Nephew PLC Info
Ticker SymbolSNN
Company nameSmith & Nephew PLC
IPO dateSep 18, 2087
CEONath (Deepak S)
Number of employees17349
Security typeDepository Receipt
Fiscal year-endSep 18
AddressBuilding 5
CityWATFORD
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited Kingdom
Postal codeWD18 8YE
Phone4401923477100
Websitehttps://www.smith-nephew.com/
Ticker SymbolSNN
IPO dateSep 18, 2087
CEONath (Deepak S)
Company Executives of Smith & Nephew PLC
Name
Name/Position
Position
Shareholding
Change
Dr. Ajay Dhankhar, Ph.D.
Dr. Ajay Dhankhar, Ph.D.
Chief Corporate Development & Strategy Officer
Chief Corporate Development & Strategy Officer
18.46K
--
Dr. Garheng Kong, M.D., Ph.D.
Dr. Garheng Kong, M.D., Ph.D.
Independent Non-Executive Director
Independent Non-Executive Director
3.00K
--
Mr. David King
Mr. David King
Non-Executive Independent Director
Non-Executive Independent Director
2.80K
--
Mr. Deepak S. Nath
Mr. Deepak S. Nath
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
2.41K
+2.16%
Mr. Paul Connolly
Mr. Paul Connolly
President - Global Operations
President - Global Operations
2.40K
+2.17%
Mr. John Ma
Mr. John Ma
Non-Executive Independent Director
Non-Executive Independent Director
1.37K
+22.23%
Mr. Mizanu Kebede
Mr. Mizanu Kebede
Chief Quality and Regulatory Affairs Officer
Chief Quality and Regulatory Affairs Officer
1.29K
+1.70%
Mr. Scott Schaffner
Mr. Scott Schaffner
President - Sports Medicine
President - Sports Medicine
1.19K
+4.86%
Mr. Craig Gaffin
Mr. Craig Gaffin
President - Orthopaedics
President - Orthopaedics
894.00
+2.57%
Ms. Elga Lohler
Ms. Elga Lohler
Chief Human Resources Officer
Chief Human Resources Officer
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Ajay Dhankhar, Ph.D.
Dr. Ajay Dhankhar, Ph.D.
Chief Corporate Development & Strategy Officer
Chief Corporate Development & Strategy Officer
18.46K
--
Dr. Garheng Kong, M.D., Ph.D.
Dr. Garheng Kong, M.D., Ph.D.
Independent Non-Executive Director
Independent Non-Executive Director
3.00K
--
Mr. David King
Mr. David King
Non-Executive Independent Director
Non-Executive Independent Director
2.80K
--
Mr. Deepak S. Nath
Mr. Deepak S. Nath
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
2.41K
+2.16%
Mr. Paul Connolly
Mr. Paul Connolly
President - Global Operations
President - Global Operations
2.40K
+2.17%
Mr. John Ma
Mr. John Ma
Non-Executive Independent Director
Non-Executive Independent Director
1.37K
+22.23%
FAQs
Who are the top five shareholders of Smith & Nephew PLC?
The top five shareholders of Smith & Nephew PLC are: Dr. Ajay Dhankhar, Ph.D.
How many institutions hold shares of Smith & Nephew PLC (SNN)?
As of 2026Q1, 471 institutions hold shares of Smith & Nephew PLC, with a combined market value of approximately 30.95M, accounting for 7.25% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -11491314.00.
What is the biggest source of revenue for Smith & Nephew PLC?
In 2026Q1, the Sports Medicine Joint Repair business generated the highest revenue for Smith & Nephew PLC, amounting to 1.07B and accounting for 17.31% of total revenue.
